The role of cytogenetic abnormalities in acute myeloid leukemia with NPM1 mutations and no FLT3 internal tandem duplication

To the editor: We read with interest the article by Haferlach et al[1][1] that concluded that cytogenetic status has no significant impact on the prognosis of patients with nucleophosmin ( NPM1 )–mutated acute myeloid leukemia (AML). Authors suggested that the favorable genotype defined by the